# OVAL Product Content Review Findings
**Date:** November 19, 2025  
**Based on:** Video transcript review of 3-tier product structure  
**Reviewed Files:** InfoTabs and Fulfillment pages for Access, One, and Plus tiers

---

## ✅ ALREADY IMPLEMENTED

### 1. Patient Assistance Program (PAP)
- **Status:** ✅ **COMPLETE**
- **Location:** All three InfoTab files (Access, One, Plus)
- **Implementation:** PAP is properly included in:
  - Key Benefits sections
  - Benefit tables with detailed descriptions
  - Mentions "medication at no cost for those who qualify for select Oval medications"

### 2. State Availability Disclaimer for Compounded Medications
- **Status:** ✅ **COMPLETE**
- **Location:** OVAL Plus InfoTab
- **Implementation:** Clear disclaimer under the map stating: 
  - "Compounded medications are not available in AL, AR, LA, MS, NC, NE, ND, VA and Puerto Rico"
  - "FDA-approved medications remain available in all service areas"

### 3. Icons in "Why Trust Oval" Section
- **Status:** ✅ **COMPLETE**
- **Location:** All three InfoTab files
- **Implementation:** Consistent icon grid with 4 items (FDA-regulated pharmacies, Licensed providers, Personalized care, Clinically proven ingredients)

### 4. Oral Medications for OVAL One
- **Status:** ✅ **COMPLETE**
- **Location:** OVAL One InfoTab
- **Implementation:** Correctly lists "Oral Medication Exclusive Pricing" and "Oral weight loss kits" (no injectable GLP-1s mentioned in key benefits)

---

## 🔴 CRITICAL CHANGES NEEDED

### 1. Make Compounded GLP-1s More Prominent in OVAL Plus
**Priority:** HIGH  
**Issue:** Compounded GLP-1s are mentioned but not as prominently as they should be given the significant cost savings ($50-100 vs $1500+)

**Current State:**
- Compounded GLP-1s are listed in tables
- Mentioned alongside branded medications
- Orange highlight exists but could be more prominent

**Recommended Changes:**
- **InfoTab:** Create a dedicated callout box for compounded GLP-1s emphasizing:
  - "Same active ingredients as Ozempic & Wegovy"
  - "Under $100/month vs $1500+ for branded"
  - "Tremendous value for significant weight loss"
- **Fulfillment Page:** Add a prominent section early in the document highlighting compounded options
- Consider adding a comparison table: Branded vs Compounded pricing

**Rationale from Video:**
> "The compounded is where customers will see a tremendous amount of value... they can get something that has the same active ingredient as Ozempic and Wegovy with the same glutide, for tens of dollars, their minds are blown. That's where customers could get the most value for their dollar."

---

### 2. Add "Future Medications" Language Across All Tiers
**Priority:** MEDIUM  
**Issue:** Need to allow for expansion of medication catalog without republishing content

**Current State:**
- OVAL One footer: "As new medications are released and approved, Oval continually evaluates..."
- OVAL Plus footer: Similar language exists
- OVAL Access: No future expansion language

**Recommended Changes:**
Add a statement to all three tiers such as:
- "**Plus many more medications** - As new treatments are released and approved, Oval continuously expands its formulary to provide members with access to the latest breakthrough therapies (including testosterone replacement therapy and other emerging treatments)"
- Alternative: "**Expanding Formulary** - New medications and treatments added regularly"

**Suggested Placement:**
- End of medication lists
- In footer notes of benefits tables
- In key benefits bullet points

**Rationale from Video:**
> "Maybe you can add, I don't know, a statement or a feature that basically allows us to have more medications... like testosterone replacement therapy, or other medications that can come out, or be part of our catalog... plus many more medications to come, or something to that effect."

---

## ⚠️ MODERATE CHANGES NEEDED

### 3. Review "FDA-Approved" Language When Custom Compounds Are Mentioned
**Priority:** MEDIUM  
**Issue:** If custom GLP-1 blends/compounds are mentioned alongside FDA-approved medications, need to clarify which are FDA-approved

**Current State in OVAL Plus InfoTab:**
- Line 140: "FDA-approved medications PLUS compounded options" ✅ (This is CORRECT)
- Line 186: "FDA-approved injectable GLP-1 medications including Wegovy..." ✅ (This is CORRECT - only lists FDA-approved)

**Action Required:**
- ✅ **Current implementation is CORRECT**
- Only the 4 branded medications (Wegovy, Ozempic, Mounjaro, Zepbound/Tirzepatide) are labeled as FDA-approved
- Compounded medications are clearly distinguished as "compounded options" or "low-cost alternatives"

**Note from Video:**
> "Since we added these custom GLP-1 blends into this description, maybe we should take out FDA-approved, because the only ones that are FDA-approved is these four."

**Resolution:** No changes needed - current implementation already handles this correctly by distinguishing between FDA-approved branded and compounded alternatives.

---

## 📊 DETAILED RECOMMENDATIONS BY TIER

### OVAL Access (Foundational Tier)

**Changes Needed:**
1. ✅ PAP already included
2. ➕ Add "expanding medication access" language
3. ✅ Icons already present

**Suggested Addition to InfoTab:**
```
"As Oval's formulary grows with new FDA-approved treatments and breakthrough therapies, 
OVAL Access members maintain full platform access to emerging healthcare solutions."
```

---

### OVAL One (Exclusive Tier)

**Changes Needed:**
1. ✅ PAP already included
2. ✅ Oral medications correctly specified (no injectable GLP-1s mentioned)
3. ➕ Add "expanding formulary" language
4. ✅ Icons already present

**Suggested Addition to Footer:**
```
"OVAL One - As new medications are released and approved, Oval continually evaluates and 
expands its formulary to provide members with access to the latest breakthrough treatments 
and therapies at exclusive member pricing, including emerging categories like testosterone 
replacement therapy and other specialty medications."
```

---

### OVAL Plus (Premium Tier)

**Changes Needed:**
1. ✅ PAP already included
2. ✅ Compounded state restrictions noted
3. 🔴 **MAKE COMPOUNDED GLP-1s MORE PROMINENT** (high priority)
4. ➕ Add "expanding formulary" language
5. ✅ Icons already present
6. ✅ FDA-approved language is already correct

**Suggested Additions:**

#### A. Prominent Compounded GLP-1 Callout Box (InfoTab):
```html
<div style="background: linear-gradient(135deg, #fff5ef 0%, #ffedd5 100%); 
            border: 2px solid #E77027; border-radius: 8px; padding: 25px; 
            margin: 25px 0; box-shadow: 0 4px 12px rgba(231, 112, 39, 0.2);">
    <h3 style="color: #E77027; margin-bottom: 15px; font-size: 20px; font-weight: 700; text-align: center;">
        💰 Compounded GLP-1 Injectable Medications - Maximum Value
    </h3>
    <p style="color: #282828; font-size: 16px; line-height: 1.6; text-align: center; margin-bottom: 15px;">
        <strong>Same active ingredients as Ozempic® and Wegovy® at a fraction of the cost</strong>
    </p>
    <div style="display: grid; grid-template-columns: 1fr 1fr; gap: 20px; margin-top: 20px;">
        <div style="text-align: center;">
            <p style="font-size: 24px; font-weight: 700; color: #dc2626; margin: 0;">$1,500+</p>
            <p style="font-size: 14px; color: #555; margin: 0;">Branded Ozempic/Wegovy</p>
        </div>
        <div style="text-align: center;">
            <p style="font-size: 24px; font-weight: 700; color: #059669; margin: 0;">Under $100</p>
            <p style="font-size: 14px; color: #555; margin: 0;">Compounded with OVAL Plus</p>
        </div>
    </div>
    <p style="color: #555; font-size: 14px; margin-top: 20px; margin-bottom: 0; text-align: center;">
        Get the same semaglutide and tirzepatide active ingredients for significant weight loss 
        at exclusive member pricing - save over $1,400/month compared to retail pharmacy prices.
    </p>
</div>
```

#### B. Update Key Benefits to Emphasize Compounded Value:
Change from:
```
<li>GLP-1 Injectable Medications: Wegovy, Ozempic, Mounjaro, Tirzepatide 
    and their low-cost alternatives with exclusive pricing</li>
```

To:
```
<li><strong style="color: #E77027;">Compounded Injectable GLP-1s:</strong> 
    Same active ingredients as Ozempic® and Wegovy® at under $100/month - 
    delivering over $1,400/month in savings while maintaining effectiveness</li>
<li><strong style="color: #333;">FDA-Approved GLP-1s:</strong> 
    Wegovy, Ozempic, Mounjaro, Zepbound - premium branded options also available 
    with exclusive member pricing</li>
```

---

## 🎯 IMPLEMENTATION PRIORITY

### Immediate (High Priority)
1. **OVAL Plus: Make compounded GLP-1s more prominent** with dedicated callout box
2. **OVAL Plus: Separate compounded from branded** in key benefits for clarity

### Short-term (Medium Priority)
3. **All Tiers: Add "expanding medications" language** to allow for future growth
4. **All Tiers: Mention specific upcoming categories** (e.g., testosterone replacement therapy)

### Review Only (Low Priority - Already Correct)
5. ✅ FDA-approved language is already properly distinguished
6. ✅ Icons are consistent across all tiers
7. ✅ PAP is implemented across all tiers
8. ✅ OVAL One correctly lists oral (not injectable) medications

---

## 📝 NOTES FROM VIDEO REVIEW

### Key Quotes:

**On Compounded GLP-1s Value:**
> "The compounded is where the customers will see a tremendous amount of value. Because like, for instance... these are obviously their manjaros, wegovy, which is, you know, out-of-pocket is extremely expensive and we could easily are under a thousand dollars for all of these. But when it comes to the compounded, you know, they're starting at $200 a month, you know, we can get it under a hundred dollars, even close to 50."

**On Making Compounded More Prominent:**
> "I think if we can kind of tie in the compounded, that's where customers could get the most value for their dollar... compounded GLP ones can be its own kind of key benefit. Where it's like compounded GLP one injectable medications. Low cost alternative with the same active ingredient as we go via an osmosis."

**On Future Medications:**
> "There's new medications that can come out at a later date. We could include more medications, like testosterone replacement therapy, or other medications that can come out, or be part of our catalog. Maybe you can add... plus many more medications to come, or something to that effect."

**On FDA-Approved Language:**
> "Since we added these custom GLP-1 blends into this description, maybe we should take out FDA-approved, because the only ones that are FDA-approved is these four."

---

## ✅ SUMMARY CHECKLIST

- [x] PAP included across all tiers
- [x] State restrictions for compounded noted (OVAL Plus)
- [x] Icons consistent across all InfoTabs
- [x] OVAL One correctly lists oral medications
- [x] FDA-approved language correctly distinguished
- [ ] **Compounded GLP-1s made more prominent in OVAL Plus**
- [ ] **"Expanding medications" language added to all tiers**
- [ ] Consider adding cost comparison graphics for compounded vs branded

---

## 📌 FINAL RECOMMENDATION

The current content is **very close to optimal**. The main areas needing attention are:

1. **Increase prominence of compounded GLP-1s** in OVAL Plus - this is where customers see the most value ($50-100 vs $1500+)
2. **Add forward-looking language** about medication expansion to all tiers
3. Everything else is already implemented correctly

The video reviewer's feedback was overwhelmingly positive ("this looks amazing... most put together and professional"), with these refinements being the final polish needed to maximize customer value perception and allow for future growth.

